In 2022, the global Biopharmaceuticals Contract Manufacturing Market reached a value of USD 13.85 Billion, with an expected annual revenue CAGR of 9% throughout the forecast period. The market's growth is primarily fueled by the effectiveness and high specificity of biologics, such as monoclonal antibodies, Vaccines, and therapeutic proteins, which have proven to be crucial in treating chronic...